ZNF274: A Potential Drug Target and Biomarker for Intellectual Disabilities
ZNF274: A Potential Drug Target and Biomarker for Intellectual Disabilities
Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in gene regulation and development. ZNF274, a specific ZFP, has been identified as a potential drug target and biomarker for intellectual disabilities. This article will discuss the ZNF274 protein, its function, and its potential as a drug target in the context of intellectual disabilities.
ZNF274: A Zinc Finger Protein
ZNF274 is a 21-kDa protein that belongs to the ZNF family. This family of proteins contains four conserved domains: a N-terminal zinc finger, a D-terminal domain, a N-terminal coiled-coil, and a C-terminal transmembrane domain. ZNF274 has a unique characteristic, a C-terminal domain that contains a unique amino acid sequence known as \"exonic splicing\" (ES). This sequence is unique among ZFPs and has been implicated in ZNF274's unique function in gene regulation.
Function of ZNF274
ZNF274 is a key regulator of gene expression and has been shown to play a role in the development and maintenance of neuronal cell types. ZNF274 has been shown to regulate the activity of several transcription factors, including NF1, NF2, and NF3. It has also been shown to interact with the protein p53 and play a role in the regulation of apoptosis.
In addition to its role in gene regulation, ZNF274 has also been shown to play a role in the development and maintenance of neural stem/progenitor cells. ZNF274 has been shown to promote the self-renewal and survival of these cells, as well as their differentiation into functional neurons.
Potential as a Drug Target
The unique function of ZNF274 and its role in gene regulation have made it an attractive target for drug development. ZNF274 has been shown to interact with several protein molecules, including the protein SMAD4. This interaction suggests that ZNF274 may be a useful target for drugs that are designed to modulate the activity of SMAD4.
In addition, ZNF274 has also been shown to interact with the protein p16INK4a. This interaction suggests that ZNF274 may be a useful target for drugs that are designed to inhibit the activity of p16INK4a.
Biomarker Potential
The potential use of ZNF274 as a biomarker for intellectual disabilities makes it an attractive target for drug development. Intellectual disabilities are a complex set of conditions that are characterized by a range of cognitive and behavioral impairments. There is a need for new diagnostic tools and approaches that can accurately and reliably diagnose and monitor these conditions.
The unique function of ZNF274 and its potential as a drug target make it an attractive candidate for the development of new diagnostic tools and approaches for intellectual disabilities. Further research is needed to fully understand the role of ZNF274 in the development and progression of intellectual disabilities, as well as its potential as a drug target.
Conclusion
ZNF274 is a unique and functionally diverse protein that has the potential to be a drug target and biomarker for intellectual disabilities. Its unique characteristics and interactions with other proteins make it an attractive target for drug development. Further research is needed to fully understand the role of ZNF274 in the development and progression of intellectual disabilities, as well as its potential as a drug target.
Protein Name: Zinc Finger Protein 274
Functions: Probable transcription repressor. Specifically binds to the 3'-end of zinc-finger coding genes and recruiting chromatin-modifying proteins such as SETDB1 and TRIM28/KAP1, leading to transcription repression. The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610)
The "ZNF274 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF274 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418
